Figure 2.
![Figure 2. Example of a positive study. Pretransplantation [18F]FDG-PET scan in a patient with diffuse large B-cell lymphoma showed intense residual [18F]FDG uptake (arrow). After HDT/SCT, the patient had a relapse and died of progressive lymphoma (PFS, 104 days; OS, 314 days). (A) Scan before the start of treatment; (B) Scan before transplantation.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/102/1/10.1182_blood-2002-12-3842/5/h81334568002.jpeg?Expires=1735604290&Signature=XowMq-81aqxunSVayZRcNtwIlEVvbhocMwJSdmCuI6-IBA7lyQ27WbxQvVLPLSXOnqj2TACo9EBzW9bSRHXplX2ucWzfUapZnNj1RmQg4VSWitKhkeEn3eJk~i-BIPJOBTV8wPtrndOV4DpLZPntpaJDZvBLUv8G7Yfg64WbnwNIoKEQiXsoTyaZvXkEeLdoBGP2i5AkA8cIv7-f9Kh2p5wOAJFj62lM4MoDnwbXYt8J7toR7ZxvEVHkCkooRHN4dbYcb0RLqaWP7cytmYY1Mp6Yd5cT4ckkGOQrYATEFd5LoZJSvbHc3idx1zsNBjBK6NsXQ0qVTsISNnHBFcC0zA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Example of a positive study. Pretransplantation [18F]FDG-PET scan in a patient with diffuse large B-cell lymphoma showed intense residual [18F]FDG uptake (arrow). After HDT/SCT, the patient had a relapse and died of progressive lymphoma (PFS, 104 days; OS, 314 days). (A) Scan before the start of treatment; (B) Scan before transplantation.
